Uxin (UXIN) EBIAT (2017 - 2025)
Uxin filings provide 9 years of EBIAT readings, the most recent being -$11.8 million for Q4 2025.
- On a quarterly basis, EBIAT rose 4.34% to -$11.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$8.6 billion, a 56.79% increase, with the full-year FY2025 number at -$37.0 million, up 21.02% from a year prior.
- EBIAT hit -$11.8 million in Q4 2025 for Uxin, up from -$8.5 billion in the prior quarter.
- In the past five years, EBIAT ranged from a high of $23.9 million in Q2 2022 to a low of -$266.1 billion in Q3 2021.
- Median EBIAT over the past 5 years was -$8.9 million (2024), compared with a mean of -$16.3 billion.
- Biggest five-year swings in EBIAT: soared 404.13% in 2022 and later tumbled 170158274.94% in 2024.
- Uxin's EBIAT stood at -$11.4 billion in 2021, then surged by 100.0% to -$14622.0 in 2022, then increased by 24.76% to -$11001.0 in 2023, then tumbled by 112398.86% to -$12.4 million in 2024, then rose by 4.34% to -$11.8 million in 2025.
- The last three reported values for EBIAT were -$11.8 million (Q4 2025), -$8.5 billion (Q3 2025), and -$9.3 million (Q2 2025) per Business Quant data.